Latest Stock Market News

Titan is expected to report 24% YoY growth in standalone jewelry sales for Q3FY25, driven by strong demand in gold jewelry and the wedding season. Despite this, a one-time inventory loss is anticipated, impacting profitability. The company’s jewelry EBIT margin is projected to decline slightly, while growth in the watches and eyewear segments remains strong.

Gold prices remained flat on February 3, following a record high in the previous session. As the US dollar strengthened due to President Trump’s new tariffs, gold futures on MCX were down slightly to Rs 82,300 per 10 grams. Spot gold fell 0.9% to $2,776.05 per ounce. Silver and other precious metals also experienced declines.

Tata’s passenger vehicle sales declined 11% in January 2025, dropping to 48,316 units from 54,033 a year ago. The automaker also reported a 25% fall in electric vehicle sales, selling 5,240 units compared to 6,979 in January 2024. The dip reflects slowing demand, posing challenges for Tata as it navigates market headwinds.

Shares of Bharat Electronics, Hindustan Aeronautics, and BHEL fell up to 7% following the Union Budget FY26 s disappointing defense allocation of Rs 4.92 lakh crore. Market expectations for a higher increase were unmet, dampening sentiment in the defense sector. Other defense stocks, including Paras Defense and MTAR Technologies, also saw significant losses due to conservative spending plans.

​I do not think anyone in the market, was expecting the slabs to go to Rs 12 lakh, so it has come as a really good positive surprise. Then, the other thing which is being spoken in the market, it is about capex.

The Union Budget 2025 boosts infrastructure financing via NaBFID, enhancing bond market liquidity and sustainable finance. A 4.4% fiscal deficit target supports INR stability, while RBI liquidity measures may stabilize bond yields. Analysts see the debt-to-GDP roadmap as positive for long-term fiscal health and expect a steady bond market ahead of the MPC meeting.

Vikas Pershad from M&G Investments maintains a positive outlook on the Indian market, despite high valuations and recent tariff announcements. He highlights opportunities in high-end expenditures, life sciences, healthcare services, and infrastructure. Pershad believes India offers significant returns in the long term, with domestic inflows and broad market growth providing support despite FII outflows.

Nomura has reaffirmed its "Buy" rating on Larsen & Toubro (L&T), citing its robust order book and execution strength. Meanwhile, Choice Broking remains positive on Ajanta Pharma, driven by its specialty therapies and margin expansion.

UPL shares surged 5% to Rs 636.45 on strong Q3 results, driven by agrochemical demand recovery. Investec upgraded UPL to buy with a Rs 700 target, while Nuvama raised its target to Rs 705. Management expects 50% YoY EBITDA growth, citing margin recovery, debt reduction, and improved business conditions.